M3 snowboard

Article source Link

CVS Caremark Corporation (NYSE:CVS) today took strong exception with a memorandum recently submitted to the Board of Directors of Longs Drug Stores Corporation (NYSE:LDG) by a law firm retained by CtW Investment Group, as follows:
We are aware that the Board of Directors of Longs recently received a memorandum from a law firm retained by the CtW Investment Group, which purports to offer an 'independent antitrust analysis of the regulatory timing and substantive risk posed by a potential acquisition of Longs by Walgreens. While not attempting an exhaustive rebuttal, we feel it is important to point out the basic factual inaccuracies and analytic deficiencies contained in this highly misleading memorandum, which attempts to equate the regulatory risks of a CVS/Longs combination and a Walgreens/Longs combination.
The Analysis Contains Numerous Inaccuracies
Some of the basic inaccuracies in the arguments made in the memorandum include:
Erroneous calculation of store overlaps.The memorandum claims that 'in CVS/Longs, the FTC chose not to engage in a long investigation even though almost 2/3 of all Longs stores overlapped with CVS stores While the memorandum did not disclose specifically how it defined an 'overlap, this assertion is plainly inaccurate, since there are 13 Metropolitan Statistical Areas (MSAs) across which Longs operates approximately 200 stores and across which CVS has none. Furthermore, in the San Francisco MSA, Longs has 22 stores while CVS has no retail pharmacies and only one specialty pharmacy and in Oakland, Longs has 62 stores while CVS has no retail pharmacies and only two specialty pharmacies. Thus, approximately 284 of Longs 521 pharmacies, or over 54%, are located in MSAs where CVS has zero retail pharmacies. Overgeneralization of store overlaps

How to skateboard

Skateboard clothes

Brown snowboarding pants

Rental apartment

Telescope beach chair

Telescope price